(DL-Isoser1)-TRAP-6 trifluoroacetate salt contains a stereochemically modified N-terminal residue that influences backbone geometry in the TRAP-6 motif. The peptide still engages receptor-binding sequences, enabling analysis of stereochemical effects. Its salt form enhances solubility in aqueous media. Researchers employ it in analog comparison, conformational studies, and receptor-activation profiling.
CAT No: C0127
CAS No:150242-29-8
Synonyms/Alias:150242-29-8;H-DL-Isoser-Phe-Leu-Leu-Arg-Asn-OH;iso-TRAP-6;(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(3-amino-2-hydroxypropanoyl)amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoic acid;(DL-Isoser1)-TRAP-6;DL-Isoser-Phe-Leu-Leu-Arg-Asn;(DL-Isoser1)-TRAP-6 trifluoroacetate salt;HY-P5001;DA-48730;FI108559;CS-0675638;(DL-Isoser 1)-TRAP-6 trifluoroacetate salt;(2S,5S,8S,11S,14S)-18-amino-2-(2-amino-2-oxoethyl)-14-benzyl-5-(3-guanidinopropyl)-17-hydroxy-8,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oic acid;
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.